116 afleveringen

Digital Health Today features the innovators, leaders and pioneers reshaping health and wellness. From patients and clinicians, to inventors and investors, we speak with guests from around the world to share their insights, experience and knowledge from the front lines of health tech innovation. Tune in, subscribe and become a part of the digital health community. Proud Member: Health Podcast Network.

Digital Health Today 360 with Dan Kendall Dan Kendall / Part of the Health Podcast Network

    • Technologie

Digital Health Today features the innovators, leaders and pioneers reshaping health and wellness. From patients and clinicians, to inventors and investors, we speak with guests from around the world to share their insights, experience and knowledge from the front lines of health tech innovation. Tune in, subscribe and become a part of the digital health community. Proud Member: Health Podcast Network.

    Coffee Talk: How Corporations Adapt in the Face of New Challenges

    Coffee Talk: How Corporations Adapt in the Face of New Challenges

    In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health Partnerships at Bayer Pharmaceuticals. I also spoke with Sophie Park. Sophie is a veteran guest on the Digital Health Today program, and the Chief Strategist for Bayer G4A Partnerships.
    Dominick shared how a chance meeting at a Washington, D.C. bar began his path to a career in Europe. We also spoke about the impact of COVID-19 on the Bayer organization, and how it has changed the expectations and opportunities for companies of all sizes working to make a dent in healthcare. He also traces the early use of the term 'digital health' back to his time at Revolution Health.
    Agents of Change - A Virtual Digital Health Forum:
    Earlier this year, Bayer G4A had a call for applications. They are looking for innovative companies that are ready to make a difference in specific key challenge areas. After months of hard work and vetting all the applicants, they’re about to announce the finalists for this year’s Bayer G4A Program. While we don’t know the companies they’ve selected at the time of this recording, they will be announced very soon at a global virtual event taking place at 11am Eastern (5PM CET) on Wednesday, November 18, 2020.
    So, if you’re listening to this episode on or before Nov 18, click here to register to attend. 
    And - if you missed it, scroll down to find names and links to the companies that have been accepted. 
    Now without further ado, let’s tune into the conversation with Dominick Kennerson and Sophie Park
    Meet the 2020 G4A Partners in the G4A Program!


    Caria - Manage menopause with confidence.


    Decipher Biosciences - A commercial-stage precision oncology company committed to improving patient care


    Sweetch - A clinically validated, personalized, AI disease management optimization platform.


    Oncare - Connects you with your care team, so that they can digitally support you in your therapy 


    Elly - Daily motivation and support for people living with a chronic condition

    
    Digital Health Today is made possible by the support of our sponsors. Thank you to:

    Bayer G4A

    Almirall Digital Garden

    Cedars-Sinai Accelerator

    University of Chicago - Master of Science in Biomedical Informatics


    Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

    Connect on Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram
    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 18 min.
    Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

    Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

    Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in Barcelona. At the start of the year, you say goodbye to your friends and family, you find a place in Barcelona to call home, and you focus on growing your business with the mentorship and support of one of the world’s leading pharmaceutical companies. 
    And then, COVID-19 happens. 
    How does that impact your strategy? How will it affect your success? And will the fight you wage for survival have an impact the healthcare sector at large?
    In this Coffee Talk we speak with Carlos Gallardo, the CEO and Founder of CG Health Ventures and a board member at Almirall. He has invested personally in about a dozen companies - including Washington DC-based Babyscripts, whose co-founder Juan Pablo Segura was a guest on episode 67. Carlos is based in Barcelona, and he often takes an active role in helping his companies develop their product market fit. 
    Background:
    At the end of 2019, Almirall selected and invited 4 companies to participate in their first cohort - aka "First Harvest" - at the Digital Garden in beautiful Barcelona. Like all things in 2020, the plans had to change to adapt to our new reality. In the face of this global crisis, the startups have embraced and benefited from opportunities that no one predicted in January. And Almirall itself has benefited from the Digital Garden as well.
    In October 2020, Almirall launched their call for their second cohort - or, as they like to call it - their "Second Harvest." 
    Find out more by visiting the Almirall Digital Garden Website. Applications are open until October 31, 2020, so don’t delay.

    Links and Resources:


    Apply to Almirall Digital Garden - Deadline is Oct 31, 2020!

    Connect with Carlos Gallardo: LinkedIn | CG Health Ventures



    Digital Garden's First Harvest:

    Haut.ai

    Derma2Go

    Uvisio

    Intrepida Analytics


    Connect on Digital Health Today:
    Browse Episodes | Twitter | Linkedin | Facebook | Instagram

    Connect on Health Podcast Network:
    Browse Shows | Linkedin | Twitter | Facebook | Instagram

    Digital Health Today is made possible by the support of our sponsors. Thank you to:

    Almirall Digital Garden

    Bayer G4A

    Cedars-Sinai Accelerator

    Medable

    University of Chicago - Master of Science in Biomedical Informatics


    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 17 min.
    What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

    What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

    If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is the first prescription treatment delivered through a video game which is designed to treat Pediatric ADHD. This was quickly followed by an announcement on June 23, 2020 of their CE Mark certification.
    Like many of you I’ve been tracking the work and progress at Akili for a long time, and I was excited to hear about this important milestone, and when the Akili team contacted me to see if I wanted to have a closer look at and try Endeavor RX, I couldn’t resist.
    I’ve downloaded it to my iPad and gave it a try, and I’m impressed. I can’t speak to the clinical aspects of the product, but based on the standards and expectations that we have from consumer focused products, this was a great experience. It’s well-designed, was easy to get set up, and it uses a great combination of graphics and sounds to engage the player. I love the way they are positioning this with the simple and memorable tagline - “Play your medicine”. That sort of sums it up.
    To learn more about the importance of this milestone and go a little deeper behind the headlines, I grabbed a few minutes to connect with Eddie Martucci, the Co-Founder and CEO at Akili Interactive Labs.
    Eddie shares what the recent FDA clearance and CE Mark approval mean to the business. We also discuss the commercialization plans, the volume and value of data created by digital tools, and how Digital Medicine and Digital Therapeutics will continue to transform the relationship between companies and people.

    Links and Resources:

    Connect with Eddie Martucci, PhD: Twitter | LinkedIn


    Connect with Akili Interactive Labs: Website | Twitter | LinkedIn


    Read the Press Release for FDA Clearance

    Read the Press Release for CE Mark Certification

    Lancet Digital Health Journal summary for STARS-ADHD


    Download the App



    Connect on Digital Health Today:
    Browse Episodes | Twitter | Linkedin | Facebook | Instagram

    Connect on Health Podcast Network:
    Browse Shows | Linkedin | Twitter | Facebook | Instagram

    Digital Health Today is made possible by the support of our sponsors. Thank you to:

    Almirall Digital Garden

    Bayer G4A

    Cedars-Sinai Accelerator

    Medable

    University of Chicago - Master of Science in Biomedical Informatics


    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 23 min.
    Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

    Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

    For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company.
    The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology. 
    One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example - a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.  
    In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family.

    Learn more about Bayer G4A Partnership

    Links and Resources:
    Learn more about Bayer G4A: Web | Twitter


    Connect on Digital Health Today:
    Browse Episodes | Twitter | Linkedin | Facebook | Instagram

    Connect on Health Podcast Network:
    Browse Shows | Linkedin | Twitter | Facebook | Instagram
     
    Digital Health Today is made possible by the support of our sponsors. Thank you to

    University of Chicago - Master of Science in Biomedical Informatics

    Almirall Digital Garden

    Bayer G4A

    Cedars-Sinai Accelerator

    Medable


    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 10 min.
    To Bot or Not to Bot? The Rise of AI Chatbots in Healthcare in the Wake of COVID-19

    To Bot or Not to Bot? The Rise of AI Chatbots in Healthcare in the Wake of COVID-19

    When you visit a website, do you use the navigation menu? Or do you head to the lower right corner of your screen? T hat corner is where a little bit of internet magic happens and it’s becoming more prevalent, and having a great impact, in healthcare. It’s where you can get the answers and information you need just by typing in a few simple words or a question.
    That little chatbot can be repeated millions and billions of times and provide more natural human interactions and benefits to both the users and the organization that deployed it.
    To learn more about this technology and how it’s being applied in healthcare, I invited Dr. John Reeves to come share some insights.  
    Dr. Reeves is a global expert in the application of conversational AI to healthcare. He has over 25 years of experience as an engineer, primary care physician, and entrepreneur. He’s the CEO and founder of ConversationHealth, which is transforming how life sciences companies engage their patients and healthcare professionals through virtual conversations. Their company has developed a Pharma-specific SaaS platform that powers these human-like experiences across text, voice, and digital human channels, and he’s here to discuss some top tips about what companies should be thinking about when it comes to developing a chatbot solution of their own.
    John and his team put together a download we’re going to discuss - and I just want to remind you that the download and links to everything we discuss can be found in the show notes of your podcast player and at our website at digitalhealthtoday.com/podcasts.
    You can also find everything at our second home on Health Podcast Network on healthpodcastnetwork.com - along with hundreds of great episodes from outstanding podcasts across healthcare. Be sure to check that out.

    Episode Download:
    Download the Chatbot Canvas

    Links and Resources:

    Connect with Dr. John Reeves: LinkedIn


    Connect with Conversation Health: Website | Twitter | LinkedIn



    Connect on Digital Health Today:
    Browse Episodes | Twitter | Linkedin | Facebook | Instagram

    Connect on Health Podcast Network:
    Browse Shows | Linkedin | Twitter | Facebook | Instagram

    Digital Health Today is made possible by the support of our sponsors. Thank you to:

    Almirall Digital Garden

    Bayer G4A

    Cedars-Sinai Accelerator

    Medable

    University of Chicago - Master of Science in Biomedical Informatics


    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 31 min.
    What Individuals and Organizations Can Do To Survive And Thrive In Times Of Crisis

    What Individuals and Organizations Can Do To Survive And Thrive In Times Of Crisis

    With the combination of the Covid crisis and the increased awareness of mental health in the month of May (which is #MentalHealthAwarenessMonth) I wanted to dig deeper into mental health and find out what we can do as individuals and organizations to resource ourselves and those around us. 
    Guest: Dr. William Kassler, Deputy Health Officer and Lead Population Health Officer at IBM Watson Health.  
    Dr. Kassler has held a variety of roles at Centers for Medicare and Medicaid Services (CMS), New Hampshire Department of Health and Human Services, and the Centers for Disease Control and Prevention (CDC). Dr. Kassler has received numerous awards from the United States Public Health Service, including the Surgeon General’s Meritorious Service Award, and the Bi-State Primary Care Association President’s Award for “unyielding dedication to community-based access to care for the poor and disadvantaged.” We certainly appreciate his dedication to serving people from across our communities.
    He’s still a practicing internist and continues to hold office hours in his role at IBM.
    In this episode, we discuss the role of self-care in developing resilience to conquer fear.
    Links and Resources Mentioned:

    Connect with Dr. William Kassler: Twitter | LinkedIn


    Connect with IBM: Website | Twitter


    2017 National Survey on Drug Use and Health (NSDUH)

    How technology and data can improve access to mental health resources


    Protecting mental health during a pandemic- By Dr. William Kassler

    IBM.biz/covidhealth - Confronting the Coronavirus - The Latest on IBM's Efforts

    Empower your remote workforce during COVID-19


    GRIT Mobile Tool For Veterans - Getting Results in Transition


    Connect on Digital Health Today:
    Browse Episodes | Twitter | Linkedin | Facebook | Instagram

    Connect on Health Podcast Network:
    Browse Shows | Linkedin | Twitter | Facebook | Instagram

    Digital Health Today is made possible by the support of our sponsors. Thank you to:

    Almirall Digital Garden

    Bayer G4A

    Cedars-Sinai Accelerator

    Medable

    University of Chicago - Master of Science in Biomedical Informatics


    Learn more about your ad choices. Visit megaphone.fm/adchoices

    • 20 min.

Top-podcasts in Technologie

Luisteraars hebben zich ook geabonneerd op